Moreover, our results resonated with Fujita’s report that elevated levels of serum Gal-9 were associated with the emergence of liver fibrosis (44), a severe form of NAFLD. This evidence concerns the gene LGALS9 and metabolic dysfunction-associated steatotic liver disease.